A Multi-stakeholder Approach to Clinical Development to Optimise Patient Access

Developing new drug therapies is complex, taking many years to move from proof of concept to final data read out from the Phase III pivotal trial. After years of substantial investment, the end goal is to bring the therapy to patients in need. Dr. Clive Whitcher and Dr. Stuart Bell at Inceptua Group discuss how a multi-stakeholder approach to clinical development will optimise patient access.